v3.26.1
Cover - shares
9 Months Ended
Apr. 30, 2026
Jun. 09, 2026
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Apr. 30, 2026  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --07-31  
Entity File Number 001-40101  
Entity Registrant Name BRIACELL THERAPEUTICS CORP.  
Entity Central Index Key 0001610820  
Entity Tax Identification Number 47-1099599  
Entity Incorporation, State or Country Code A1  
Entity Address, Address Line One 235 15th Street, Suite 300  
Entity Address, City or Town West Vancouver  
Entity Address, State or Province BC  
Entity Address, Postal Zip Code V7T 2X1  
City Area Code 604  
Local Phone Number 921-1810  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,699,787
Common shares, no par value    
Title of 12(b) Security Common shares, no par value  
Trading Symbol BCTX  
Security Exchange Name NASDAQ  
Warrants to purchase common shares, no par value    
Title of 12(b) Security Warrants to purchase common shares, no par value  
Trading Symbol BCTXW  
Security Exchange Name NASDAQ  
Warrants to purchase common shares no par value [Member]    
Title of 12(b) Security Warrants to purchase common shares, no par value  
Trading Symbol BCTXZ  
Security Exchange Name NASDAQ  
Warrants to purchase common shares no par value [Member]    
Title of 12(b) Security Warrants to purchase common shares, no par value  
Trading Symbol BCTXL  
Security Exchange Name NASDAQ